This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Avelumab-Cetuximab-RT vs. SoC in Locally Advanced HNSCC - Final Analysis From the REACH Trial

135 views
September 20, 2024
Comments 0
Login to view comments. Click here to Login